Search
for
Sort by
Research 151–180 of 288
- Impact of estrogens in males and androgens in females
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Molecular mechanisms of asymmetric divisions in mammary stem cells
- New insights into the role of Runx1 in epithelial stem cell biology and pathology
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- p63: a crucial player in epithelial stemness regulation
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- S100A6: molecular function and biomarker role
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Leveraging nature’s nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications
- Ethnopharmacological Significance of <i>Eclipta alba</i> (L.) Hassk. (Asteraceae)
- Controllable Production of Transplantable Adult Human High-Passage Dermal Papilla Spheroids Using 3D Matrigel Culture
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- PROTACs: A novel strategy for cancer drug discovery and development
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications
- Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- The role of WNT10B in physiology and disease: A 10-year update
- Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation
- Genetically modified laboratory mice with sebaceous glands abnormalities
- Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia
- Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor